Cellectar Earns $2M SBIR Contract
Cellectar Biosciences announced today it is the recipient of the second phase of a National Cancer Institute Fast-Track SBIR contract worth $2 million. According to a release, the money will be used to…
Category Archives: Biotech
FluGen Starts Clinical Trial of Vaccine
FluGen announced today it has begun a Phase I clinical trial of its universal influenza vaccine called RedeeFlu. “The initiation of this first-in-man study is an important milestone achieved through…
HEDIS Quality Measures May Include Cologuard
Exact Sciences announced this week that Cologuard could be included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening following a proposal from the…
SHINE, HTA to Collaborate
SHINE Medical Technologies announced today that is has entered into a strategic agreement with the largest Chinese producer and distributor of radio-pharmaceuticals, HTA, to help with the supply of molybdenum (moly-99). “HTA…
Cologuard Adds Coverage
Exact Sciences is now an in-network provider of Cologuard with Anthem Blue Cross and Blue Shield in five additional states, the organization announced Wednesday. “As Cologuard’s in-network status grows in…
Cellectar Issued New Patent
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent that covers CLR 1603, a phospholipid ether-paclitaxel conjugate, the company announced recently. “This first issued patent under our CLR CTX…
CDI Partners with Michael J. Fox Foundation
To provide resources for developing new therapies, Cellular Dynamics International, a FUJIFILM company, announced Wednesday a partnership with The Michael J. Fox Foundation for Parkinson’s Research. “Our partnership with The…
Stemina Rebrands Its Diagnostics
Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a division of Stemina,…
40K Cologuard Tests Completed in Q1
Exact Sciences announced today that approximately 40,000 Cologuard tests were completed in the first quarter of 2016. “Our first quarter performance reflects sequential growth and another significant year-over-year increase, the result…
SHINE CEO Strives to Help Society
Greg Piefer is ambitious, to say the least. The CEO of SHINE Medical Technologies expects his company to create a reliable supply of the medical ingredients, including molybdenum-99, required by nearly…
